The role of nanobacteria in urologic disease
- PMID: 16402263
- DOI: 10.1007/s00345-005-0041-3
The role of nanobacteria in urologic disease
Abstract
Recent data proposing an extremely small, self-replicating agent termed "nanobacteria" has raised a great deal of controversy within the scientific community. Since these agents have been isolated within the genitourinary tract, much research has focused attention on the potential role these particles may play in the development of urologic pathology, including polycystic kidney disease, renal calculi, and chronic prostatitis. Recent clinical research targeting these agents has proven effective in treating some patients with refractory category III prostatitis (chronic pelvic pain syndrome). This article reviews the current state of nanobacteria research and explore where these particles may impact urologic disease.
Similar articles
-
Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience.J Urol. 2005 Feb;173(2):474-7. doi: 10.1097/01.ju.0000150062.60633.b2. J Urol. 2005. PMID: 15643213 Clinical Trial.
-
Prostatitis: the role of antibiotic treatment.World J Urol. 2003 Jun;21(2):105-8. doi: 10.1007/s00345-003-0333-4. Epub 2003 Apr 10. World J Urol. 2003. PMID: 12687400 Review.
-
Lithogenesis: induction of renal calcifications by nanobacteria.Urol Res. 2006 Feb;34(1):53-7. doi: 10.1007/s00240-005-0034-0. Epub 2006 Jan 20. Urol Res. 2006. PMID: 16425019
-
The Urinary Tract Microbiome in Health and Disease.Eur Urol Focus. 2018 Jan;4(1):128-138. doi: 10.1016/j.euf.2016.11.001. Epub 2016 Nov 14. Eur Urol Focus. 2018. PMID: 28753805 Review.
-
Detection of nanobacteria infection in type III prostatitis.Urology. 2008 Jun;71(6):1091-5. doi: 10.1016/j.urology.2008.02.041. Urology. 2008. PMID: 18538692 Clinical Trial.
Cited by
-
Resistance of nanobacteria isolated from urinary and kidney stones to broad-spectrum antibiotics.Iran J Microbiol. 2014 Aug;6(4):230-3. Iran J Microbiol. 2014. PMID: 25802705 Free PMC article.
-
Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment.Int Urogynecol J. 2010 Jan;21(1):103-9. doi: 10.1007/s00192-009-0994-7. Epub 2009 Sep 17. Int Urogynecol J. 2010. PMID: 19760079
-
Evaluation of chronic pelvic pain syndrome in men: is it chronic prostatitis?Curr Urol Rep. 2009 Jul;10(4):295-301. doi: 10.1007/s11934-009-0048-1. Curr Urol Rep. 2009. PMID: 19570491
-
Detection of nanobacteria in patients with chronic prostatitis and vaginitis by reverse transcriptase polymerase chain reaction.Korean J Urol. 2011 Mar;52(3):194-9. doi: 10.4111/kju.2011.52.3.194. Epub 2011 Mar 18. Korean J Urol. 2011. PMID: 21461284 Free PMC article.
-
Tetracycline attenuates calcifying nanoparticles-induced renal epithelial injury through suppression of inflammation, oxidative stress, and apoptosis in rat models.Transl Androl Urol. 2019 Dec;8(6):619-630. doi: 10.21037/tau.2019.11.14. Transl Androl Urol. 2019. PMID: 32038958 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical